CALL - SPRINTER OPEN END - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 19:04:43 17/05/2024 BST | ||
| 1.84 EUR | -0.54% |
|
| Current month | +0.55% | ||
| 1 month | +32.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/05/24 | 1.84 | -0.54% |
| 16/05/24 | 1.85 | -1.07% |
| 15/05/24 | 1.87 | +16.15% |
| 14/05/24 | 1.61 | -2.42% |
| 13/05/24 | 1.65 | -9.34% |
Real-time Boerse Frankfurt Warrants
Last update May 17, 2024 at 07:04 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM7XBA |
| ISIN | DE000VM7XBA3 |
| Date issued | 03/01/2024 |
| Strike | 111.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.07 € |
|---|---|
| Lowest since issue | 0.56 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2
USD
Average target price
141.6
USD
Spread / Average Target
+7.96%
- Stock Market
- Certificates
- Certificat
